Macrocure Ltd. - Ordinary Share (MCUR) Stock Price, News & Analysis

Company Overview

Leap Therapeutics Ltd, formerly Macrocure Ltd, is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs for the treatment of chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is a combination of living human white blood cells that have been activated to facilitate the healing process and stimulate wound closure. CureXcell is in Phase III. Its CureXcell addresses each phase of healing in the impaired wound, including the production of growth factors and other biochemical factors involved in fibroblast activation, cell migration and extracellular matrix production, stimulating the body's natural healing process. Its delivery method of direct superficial injection into the chronic wound allows the precise delivery of the cells into the defective wound tissue where they can be effective.

Key Stats

• Today's Range: $1.51 to $1.51
• 50-Day Range: N/A
• 52-Week Range: $0.75 to $3.20
• Volume: N/A
• Average Volume: 98,746 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MCUR Stock Analysis - Frequently Asked Questions

How were Macrocure Ltd. - Ordinary Share's earnings last quarter?

Macrocure Ltd. - Ordinary Share (NASDAQ:MCUR) announced its earnings results on Tuesday, November, 17th. The biotechnology company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.04.

What other stocks do shareholders of Macrocure Ltd. - Ordinary Share own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Macrocure Ltd. - Ordinary Share investors own include LinnCo (LNCOQ), California Resources (CRC), (GBSN) (GBSN), (BBEPQ) (BBEPQ), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), (UPLMQ) (UPLMQ) and U.S. Energy (USEG).

Company Calendar

• Last Earnings: 11/17/2015
• Today: 12/21/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MCUR
• CUSIP: N/A
• CIK: 1606012
• Web: www.macrocure.com
• Phone: +972-3-9235556
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A